(Q36070903)

12 August 2017

1 reference

title

Community-associated methicillin-resistant Staphylococcus aureus: a review (English)

1 reference

methicillin-resistant Staphylococcus aureus

12 August 2017

main subject

0 references

Staphylococcus aureus

object named as

Staphylococcus aureus

1 reference

1

Michael J Rybak

1 reference

12 August 2017

Kerry L LaPlante

2

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

12 August 2017

1 reference

12 August 2017

volume

25

1 reference

12 August 2017

issue

1

1 reference

12 August 2017

page(s)

74-85

1 reference

The changing epidemiology of Staphylococcus aureus?

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Staphylococcus aureus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Prediction Model to Identify Patients WithStaphylococcus aureusBacteremia at Risk for Methicillin Resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Nosocomial bloodstream infections: organisms, risk factors, and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Emergence of methicillin-resistant Staphylococcus aureus with intermediate glycopeptide resistance: clinical significance and treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Methicillin-resistant Staphylococcus aureus (MRSA): a community-based prevalence survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Phenotypic and molecular characterization of community occurring, Western Samoan phage pattern methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Methicillin-resistant Staphylococcus aureus in the community: new battlefronts, or are the battles lost?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Prevalence of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus in Minnesota, 1996-1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Emergence of methicillin-resistant Staphylococcus aureus as a community pathogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Population-based incidence and characteristics of community-onset Staphylococcus aureus infections with bacteremia in 4 metropolitan Connecticut areas, 1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Community-acquired methicillin-resistant Staphylococcus aureus skin infection: an emerging clinical problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Emergence of community-associated methicillin-resistant Staphylococcus aureus at a Memphis, Tennessee Children's Hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Community-acquired methicillin-resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Comparative molecular analysis of community- or hospital-acquired methicillin-resistant Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Severe Staphylococcus aureus Infections Caused by Clonally Related Community-Acquired Methicillin-Susceptible and Methicillin-Resistant Isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA)

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Novel type V staphylococcal cassette chromosome mec driven by a novel cassette chromosome recombinase, ccrC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Novel type of staphylococcal cassette chromosome mec identified in community-acquired methicillin-resistant Staphylococcus aureus strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

A novel methicillin-resistance cassette in community-acquired methicillin-resistant Staphylococcus aureus isolates of diverse genetic backgrounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Panton-valentine leukocidin and staphyloccoccal skin infections in schoolchildren

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Genome and virulence determinants of high virulence community-acquired MRSA

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Characterization and biological properties of a new staphylococcal exotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Community-onset methicillin-resistant Staphylococcus aureus associated with antibiotic use and the cytotoxin Panton-Valentine leukocidin during a furunculosis outbreak in rural Alaska

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Widespread skin and soft-tissue infections due to two methicillin-resistant Staphylococcus aureus strains harboring the genes for Panton-Valentine leucocidin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Methicillin-resistant Staphylococcus aureus. Epidemiologic observations during a community-acquired outbreak

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

The spread of methicillin-resistant Staphylococcus aureus in a rural community: will it become a common microorganism colonizing among the general population?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Community-acquired methicillin-resistant Staphylococcus aureus infection in Singapore is usually "healthcare associated".

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

An outbreak of community-onset methicillin-resistant Staphylococcus aureus skin infections in southwestern Alaska

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Staphylococcus aureus nasal carriage in the community: a survey from central Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Identification of a novel methicillin-resistant Staphylococcus aureus epidemic clone in Córdoba, Argentina, involved in nosocomial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Community-acquired methicillin-resistant Staphylococcus aureus isolated in Switzerland contains the Panton-Valentine leukocidin or exfoliative toxin genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Community-acquired methicillin-resistant Staphylococcus aureus in southern New England children

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

New trends in Staphylococcus aureus infections: glycopeptide resistance in hospital and methicillin resistance in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Community-acquired methicillin-resistant Staphylococcus aureus skin infection: a retrospective analysis of clinical presentation and treatment of a local outbreak

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Daptomycin Dose-Effect Relationship against Resistant Gram-Positive Organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Failure of Clindamycin Treatment of Methicillin-Resistant Staphylococcus aureus Expressing Inducible Clindamycin Resistance In Vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Absence of Cross-Reactivity between Sulfonamide Antibiotics and Sulfonamide Nonantibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Minocycline versus vancomycin for treatment of experimental endocarditis caused by oxacillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Rapid development of ciprofloxacin resistance in methicillin-susceptible and -resistant Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Vancomycin resistance in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Linezolid resistance in Staphylococcus aureus: characterization and stability of resistant phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Safety and tolerability of quinupristin/dalfopristin: administration guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

In vitro activities of daptomycin against 2,789 clinical isolates from 11 North American medical centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

Bactericidal activities of two daptomycin regimens against clinical strains of glycopeptide intermediate-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecium, and methicillin-resistant Staphylococcus aureus isolates in an in vi

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.74.55620

10.1592/PHCO.25.1.74.55620

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference